{ "docId": "019de074-dc20-710d-9b43-f177871cdc93", "docSlug": "4b9e8528511ce76bfc3efc6d54c66694", "documentTitle": "Cano Health | Investor Presentation Deck | 48 slides", "authorId": "cano-health", "authorName": "Cano Health", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "pageCount": 48, "prevPage": 1, "nextPage": 3, "slideType": "disclaimer", "function": "other", "density": "dense", "nDataPoints": 0, "notes": null, "elementsJson": null, "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019de074-dc20-710d-9b43-f177871cdc93/2", "deckHref": "/decks/019de074-dc20-710d-9b43-f177871cdc93", "deckJsonHref": "/decks/019de074-dc20-710d-9b43-f177871cdc93.json", "deckAnchorHref": "/decks/019de074-dc20-710d-9b43-f177871cdc93#slide-2", "components": [ { "bbox": { "h": 0.45, "w": 0.92, "x": 0.04, "y": 0.11 }, "kind": "disclaimer", "text": "GENERAL: This presentation (\"Presentation\") is for informational purposes only to assist investors, prospective investors and other parties (\"Recipients\") in making their own evaluation with respect to Cano Health, Inc. (\"Cano Health\" or the \"Company\", \"our\" or words of similar import). The information contained herein does not purport to be all-inclusive, and neither the Company nor any of its nor any of its respective affiliates, directors, officers, employees, agents, shareholders or advisors (collectively, \"Representatives\") makes any representation or warranty, express or implied, as to the accuracy, completeness, or reliability of the information contained in this Presentation. Certain information contained in this Presentation relates to or is based on studies, publications, surveys, and the Company's own internal estimates and research. To the extent available, the industry, market and competitive position data contained in this Presentation are sourced from official or third-party sources. Third party industry publications, studies and surveys generally state that the data contained therein have been obtained from sources believed to be reliable, but that there is no guarantee of the accuracy or completeness of such data. The Company has not independently verified the data contained therein. In addition, certain of the industry, market and competitive position data contained in this Presentation may be sourced from the Company's own internal estimates based on the knowledge and experience of the Company's management in the markets in which the Company operates. This data and its underlying methodology and assumptions have not been verified by any independent source for accuracy or completeness and are subject to change without notice. Accordingly, undue reliance should not be placed on any of the industry, market or competitive position data contained in this Presentation. In addition, certain data and other information included in this Presentation are based on a number of assumptions and limitations, and there can be no guarantee as to the accuracy or reliability of such assumptions. Finally, while the Company believes its internal research is reliable, such research has not been verified by any independent source. The Company has not yet completed its quarter and year-end financial close processes for the quarter and year ended December 31, 2022. The preliminary, estimated financial results presented herein have not been audited and are based on information currently available to the Company. Accordingly, such results are subject to revision as a result of the Company's completion of its normal quarter and year-end accounting closing procedures, including customary reviews and approvals, completion by the Company's independent registered public accounting firm of its audit of such financial statements, asset recoverability accounting analysis, the execution of its internal controls over financial reporting, final adjustments and other developments arising between now and the time that our financial results for the three months and year ended December 31, 2022 are finalized. As such, the Company's actual results may materially vary from the preliminary results presented in this Presentation.", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "7485f6d6-bb3b-400e-baef-7c34a994752d", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.38, "w": 0.92, "x": 0.04, "y": 0.57 }, "kind": "disclaimer", "text": "FORWARD-LOOKING STATEMENTS: This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to future events and involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and could materially affect actual results, performance or achievements. These forward-looking statements generally can be identified by phrases such as \"will,\" \"expects,\" \"anticipates,\" \"foresees,\" \"forecasts,\" \"estimates\" or other words or phrases of similar import, including, without limitation, (i) our belief that we have a strong foundation for value creation, a clear path for sustainable profitability and an experienced and Independent Board committed to taking necessary action, as well as a clear strategy to drive value creation for all stockholders and our expected benefits from implementing our business strategies and plans, such as improving our cost structure, including our plans to reduce annual SG&A expenses by $70 million in 2023, improving our operating cash flow, simplifying and optimizing our business model, optimizing our management and governance, improving and accelerating our earnings trajectory, achieving long-term sustainable growth and profitability, and building long-term value; (ii) our belief that with a track record of industry-leading clinical outcomes and patient engagement, we are uniquely positioned to capture additional share of a compelling market opportunity and help patients live longer and healthier lives; (iii) our plans to accelerate our path to positive free cash flow to reduce long-term debt and leverage ratios, as part of our long-term capital management strategy; (iv) our plans to pursue the divestiture of certain non-core assets to strengthen our focus on our high-performing Medicare Advantage business; (v) our financial guidance for 2023; (vi) our plans to implement the reverse stock split; (vii) our belief that we have sufficient total liquidity and are well positioned to fund our strategic plan; (viii) our belief that Cano Health is uniquely positioned to capture share of a $1.7 trillion total addressable market; (ix) our belief that we are meaningfully undervalued and poised to accelerate results in coming quarters to close the gap between our embedded value versus market value and deliver approximately 100%+ of stockholder value; and (x) based on the historic performance of our more established medical centers, our plans to unlock substantial embedded profitability as our medical centers continue to mature and our belief that our prior investments in de novo medical centers yield significant embedded opportunity and that the maturation of de novo and existing medical centers presents a significant Adjusted EBITDA opportunity over time. These forward-looking statements are based on information available to us at the time of this presentation and our current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. We derive many of our forward-looking statements from our operating budgets and forecasts, which are based on many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known or unknown factors, and it is impossible for us to anticipate all factors that could affect our actual results. It is uncertain whether any of the events anticipated by our forward-looking statements will transpire or occur, or if any of them do, what impact they will have on our results of operations and financial condition. Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in our forward-looking statements include, among others, changes in market or industry conditions, changes in the regulatory environment, competitive conditions, and/or consumer receptivity to our services; changes in our strategy, future prospects and plans; developments and uncertainties related to the Direct Contracting Entity program; our ability to realize expected financial results, including with respect to patient membership, total revenue and earnings; our ability to predict and control our medical cost ratio; our ability to grow market share in existing markets and continue our growth; our ability to integrate our acquisitions and achieve desired synergies; our ability to maintain our relationships with health plans and other key payors; our future capital requirements and sources and uses of cash, including funds to satisfy our liquidity needs; our ability to attract and retain members of management and our Board of Directors; and/or our ability to recruit and retain qualified team members and independent physicians.", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "a61d8f07-0bd1-42b1-bc68-3b288291326b", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.04, "w": 0.12, "x": 0.04, "y": 0.0935 }, "kind": "image", "text": "CanoHealth", "attrs": null, "subkind": "logo", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "7e50728e-31b1-49b3-a080-93dc764aab7a", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.06, "w": 0.16, "x": 0.04, "y": 0.03 }, "kind": "title", "text": "Disclaimer", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "eaaa6f41-970b-40f9-a705-c31f35bcbe9e", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 4, "from": 1, "beatId": "dd409c41-8073-495d-8ebd-b7d3cc81d209", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Setup", "beatSlug": "setup", "evidence": "Introduction to Cano Health and its mission", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "loops": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }